Vitamin B12 trial aims to stop Chemo's painful side effect
NCT ID NCT07423390
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether taking mecobalamin (a form of vitamin B12) can prevent or reduce nerve damage caused by taxane chemotherapy. About 326 adults with various solid tumors will take mecobalamin tablets or receive no preventive treatment during their chemo. The goal is to see if fewer people develop numbness, tingling, or pain in their hands and feet.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- mecobalamin (a form of vitamin B12)
- What this could lead to
- If it works, this could provide a simple, low-cost way to prevent painful nerve damage during chemotherapy.
- What could go wrong
- This is a single-center trial, and the benefit may be modest or not confirmed. Mecobalamin is generally safe but may not prevent all nerve symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Cancer Hospital of Shandong First Medical University (Shandong Cancer Hospital)
NOT_YET_RECRUITINGJinan, Shandong, China
-
Affiliated Hospital of Qinghai University
NOT_YET_RECRUITINGXining, Qinghai, China
-
Beijing Chaoyang Sanhuan Cancer Hospital
RECRUITINGBeijing, China
-
Qinghai Red Cross Hospital
RECRUITINGXining, Qinghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug shield nerves from Chemotherapy's side effects?
- Can a Tumor's DNA guide better cancer care for kids?
- Can a new PET tracer reveal a key cancer target?
- Can a smart drug home in on Hard-to-Treat cancers?
- Can a new tracer light up cancer growth?
- Can a Dual-Pronged antibody outsmart advanced cancers?